Showing results (131-140 of 162) with videos related to
Sort By:
Pageof 17
BMJ Oncology|January 31, 2025
Thirty years from FDA approval of pegylated liposomal doxorubicin (Doxil/Caelyx): an updated analysis and future perspectiveAlberto A Gabizon, Shira Gabizon-Peretz, Shadan Modaresahmadi, et al.BMJ Oncology|January 31, 2025
Gender disparities in clinical outcomes of urothelial carcinoma linked to X chromosome gene KDM6A mutationZhaopei Liu, Kaifeng Jin, Ziyue Xu, et al.BMJ Oncology|January 31, 2025
Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019Jianhui Zhao, Liying Xu, Jing Sun, et al.BMJ Oncology|January 31, 2025
Prevalence of MRI lesions in men responding to a GP-led invitation for a prostate health check: a prospective cohort studyCaroline M Moore, Elena Frangou, Neil McCartan, et al.BMJ Oncology|January 31, 2025
Cardiovascular health: an important component of cancer survivorshipSiobhan Cleary, Stuart D Rosen, Duncan C Gilbert, et al.BMJ Oncology|January 31, 2025
Baseline tumour vessel perfusion as a non-invasive predictive biomarker for immune checkpoint therapy in non-small-cell lung cancerZhenhua Liu, Ke Ma, Qingzhu Jia, et al.BMJ Oncology|January 31, 2025
Vitamin B6 status and chronic chemotherapy-induced peripheral neuropathy: a prospective cohort study among patients with non-metastatic colorectal cancer receiving oxaliplatin-based chemotherapyLisanne Renting, Nienke R K Zwart, Per Magne Ueland, et al.BMJ Oncology|January 31, 2025
Assessing the rates of false-positive ovarian cancer screenings and surgical interventions associated with screening tools: a systematic reviewSierra M Silverwood, Grant Backer, Annie Galloway, et al.BMJ Oncology|January 31, 2025
Benefits and harms of breast cancer screening revisited: a large, retrospective cross-sectional study quantifying treatment intensity in women with screen-detected versus non-screen-detected cancer in Australia and New ZealandKathy Dempsey, Daniel Sj Costa, Meagan E Brennan, et al.BMJ Oncology|January 31, 2025
Time trends in health-related quality of life assessment and reporting within publications of oncology randomised phase III trials: a meta-research studyLaura Marandino, Federica Trastu, Eleonora Ghisoni, et al.Pageof 17